Pharmaron Beijing Co., Ltd. (HKG:3759)
13.70
-0.12 (-0.87%)
May 13, 2025, 1:44 PM HKT
Pharmaron Beijing Revenue
Pharmaron Beijing had revenue of 3.10B CNY in the quarter ending March 31, 2025, with 16.03% growth. This brings the company's revenue in the last twelve months to 12.70B, up 10.61% year-over-year. In the year 2024, Pharmaron Beijing had annual revenue of 12.28B with 6.39% growth.
Revenue (ttm)
12.70B CNY
Revenue Growth
+10.61%
P/S Ratio
3.04
Revenue / Employee
594.47K CNY
Employees
21,370
Market Cap
41.39B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12.28B | 737.78M | 6.39% |
Dec 31, 2023 | 11.54B | 1.27B | 12.39% |
Jan 1, 2023 | 10.27B | 2.82B | 37.92% |
Dec 31, 2021 | 7.44B | 2.31B | 45.00% |
Dec 31, 2020 | 5.13B | 1.38B | 36.64% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 32.49B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
Alibaba Health Information Technology | 31.39B |
Akeso | 2.26B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |